118 related articles for article (PubMed ID: 23721930)
1. Predicting metachronous liver metastasis from colorectal cancer using serum proteomic fingerprinting.
Zhu D; Zhong Y; Wu H; Ye L; Wang J; Li Y; Wei Y; Ren L; Xu B; Xu J; Qin X
J Surg Res; 2013 Oct; 184(2):861-6. PubMed ID: 23721930
[TBL] [Abstract][Full Text] [Related]
2. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
3. [High concentration of E-cadherin in portal drainage vein of colorectal cancer patients may predict metachronous liver metastasis].
Ohue M; Takahashi K; Yamaguchi T; Murata Y; Tanaka S; Umekita N; Mori T
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2263-6. PubMed ID: 12484050
[TBL] [Abstract][Full Text] [Related]
4. Biliary carcinoembryonic antigen levels can predict metachronous liver metastasis of colorectal cancer.
Ishida H; Yoshinaga K; Gonda T; Ando M; Hojo I; Fukunari H; Iwama T; Mishima Y
Anticancer Res; 2000; 20(1B):523-6. PubMed ID: 10769718
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of serum CEA, CA19-9 and CA125 in diagnosis of colorectal liver metastasis in Chinese population.
Zhang D; Yu M; Xu T; Xiong B
Hepatogastroenterology; 2013 Sep; 60(126):1297-301. PubMed ID: 23933921
[TBL] [Abstract][Full Text] [Related]
6. [Survival of patients with liver metastasis from colorectal cancer by different modes of therapy: a report of 363 cases].
Xu JM; Qin XY; Zhong YS; Wei Y; Fan J; Zhou J; Qin LX; Wang JH; Yan ZP; Cheng JM; Wu ZH
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):54-7. PubMed ID: 17575696
[TBL] [Abstract][Full Text] [Related]
7. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
[TBL] [Abstract][Full Text] [Related]
8. [Application of SELDI-TOF-MS in detection of liver metastasis from colorectal cancer].
Shi YJ; Zhao Y; Xu JM; Lai YH; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):910-3. PubMed ID: 19173991
[TBL] [Abstract][Full Text] [Related]
9. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
[TBL] [Abstract][Full Text] [Related]
10. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
[TBL] [Abstract][Full Text] [Related]
11. Preoperative serum level of CA19-9 predicts recurrence after curative surgery in node-negative colorectal cancer patients.
Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
Hepatogastroenterology; 2003; 50(51):696-9. PubMed ID: 12828063
[TBL] [Abstract][Full Text] [Related]
12. Value of serum carbohydrate antigen 19-9 for predicting extrahepatic metastasis in patients with liver metastasis from colorectal carcinoma.
Sasaki A; Kawano K; Inomata M; Shibata K; Matsumoto T; Kitano S
Hepatogastroenterology; 2005; 52(66):1814-9. PubMed ID: 16334783
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery.
Park IJ; Kim HC; Yu CS; Kim PN; Won HJ; Kim JC
Ann Surg Oncol; 2008 Jan; 15(1):227-32. PubMed ID: 17882491
[TBL] [Abstract][Full Text] [Related]
14. Is delayed liver resection appropriate for patients with metachronous colorectal metastases?
Ueno S; Sakoda M; Kitazono M; Iino S; Kurahara H; Minami K; Ando K; Mataki Y; Maemura K; Ishigami S; Natsugoe S
Ann Surg Oncol; 2011 Apr; 18(4):1104-9. PubMed ID: 21046261
[TBL] [Abstract][Full Text] [Related]
15. Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis.
Toiyama Y; Miki C; Inoue Y; Kawamoto A; Kusunoki M
J Surg Oncol; 2009 May; 99(6):368-72. PubMed ID: 19204971
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of serum NCC-ST 439 as a tumor marker for colorectal cancer].
Yamaguchi A; Kurosaka Y; Ohta N; Kamata T; Ishida T; Nishimura G; Katoh M; Kosaka T; Yonemura Y; Miyazaki I
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2645-50. PubMed ID: 2549882
[TBL] [Abstract][Full Text] [Related]
17. Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer.
Tsushima H; Ito N; Tamura S; Matsuda Y; Inada M; Yabuuchi I; Imai Y; Nagashima R; Misawa H; Takeda H; Matsuzawa Y; Kawata S
Clin Cancer Res; 2001 May; 7(5):1258-62. PubMed ID: 11350892
[TBL] [Abstract][Full Text] [Related]
18. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
[TBL] [Abstract][Full Text] [Related]
19. Metastatic potential in T1 and T2 colorectal cancer.
Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for the development of metachronous liver metastasis in colorectal cancer patients after curative resection.
Chuang SC; Su YC; Lu CY; Hsu HT; Sun LC; Shih YL; Ker CG; Hsieh JS; Lee KT; Wang JY
World J Surg; 2011 Feb; 35(2):424-9. PubMed ID: 21153819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
